DUOGENIC STEMCELLS Trademark
Trademark Overview
On Tuesday, May 31, 2022, a trademark application was filed for DUOGENIC STEMCELLS with the United States Patent and Trademark Office. The USPTO has given the DUOGENIC STEMCELLS trademark a serial number of 97436439. The federal status of this trademark filing is REGISTERED as of Tuesday, August 1, 2023. This trademark is owned by DuoGenic StemCells corporation. The DUOGENIC STEMCELLS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Cultured cell bank services for medical transplantation; Medical services relating to the removal, treatment and processing of human cells; Medical services relating to the removal, treatment and processing of stem cells; Medical treatment using cultured cells; Stem cell therapy services; Medical treatment of degenerative arthritis, osteonecrosis, Carpal tunnel syndrome, sports injury using cultured cells
General Information
| Serial Number | 97436439 |
| Word Mark | DUOGENIC STEMCELLS |
| Filing Date | Tuesday, May 31, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 1, 2023 |
| Registration Number | 7125125 |
| Registration Date | Tuesday, August 1, 2023 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, May 16, 2023 |
Trademark Statements
| Description of Mark | The mark consists of the stylized wording "DUOGENIC STEMCELLS". |
| Pseudo Mark | DUO GENIC STEM CELLS |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Cultured cell bank services for medical transplantation; Medical services relating to the removal, treatment and processing of human cells; Medical services relating to the removal, treatment and processing of stem cells; Medical treatment using cultured cells; Stem cell therapy services; Medical treatment of degenerative arthritis, osteonecrosis, Carpal tunnel syndrome, sports injury using cultured cells |
| Disclaimer with Predetermined Text | "STEMCELLS" |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 7, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, February 1, 2019 |
| First Use In Commerce Date | Friday, February 1, 2019 |
Trademark Owner History
| Party Name | DuoGenic StemCells corporation |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Taichung City 411021
TW |
| Party Name | DuoGenic StemCells corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Taichung City 411021
TW |
| Party Name | DuoGenic StemCells corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Taichung City 411021
TW |
Trademark Events
| Event Date | Event Description |
| Tuesday, August 1, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 1, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 16, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 16, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 26, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 12, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, March 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 30, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 15, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 15, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 15, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 15, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, June 7, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, June 3, 2022 | NEW APPLICATION ENTERED |
